224 related articles for article (PubMed ID: 34629350)
1. [Consideration on Academia Environments for Creating Medical Innovation].
Iida K; Ishida T; Nishimura N
Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
[TBL] [Abstract][Full Text] [Related]
2. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
[TBL] [Abstract][Full Text] [Related]
3. The path to producing pharmaceuticals from natural products uncovered by academia-from the perspective of a science coordinator.
Fujie A
Biosci Biotechnol Biochem; 2017 Jan; 81(1):38-42. PubMed ID: 27885934
[TBL] [Abstract][Full Text] [Related]
4. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
5. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
6. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
Takebe T; Imai R; Ono S
Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
[TBL] [Abstract][Full Text] [Related]
7. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
[TBL] [Abstract][Full Text] [Related]
8. Academic collaborations with industry: lessons for the future.
Reddy SSK; Chao S
J Investig Med; 2020 Dec; 68(8):1305-1308. PubMed ID: 33168581
[TBL] [Abstract][Full Text] [Related]
9. [Strategic construction of an innovative drug development pipeline by industry-academia cooperation - consortium for drug innovation in the Tokai region of Japan].
Akaike A
Nihon Yakurigaku Zasshi; 2014 May; 143(5):254-9. PubMed ID: 24813797
[No Abstract] [Full Text] [Related]
10. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
Palmer M; Chaguturu R
Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
[No Abstract] [Full Text] [Related]
11. [Problems with Laboratory Notebooks in Academia and How to Resolve Them].
Kakuta H
Yakugaku Zasshi; 2019; 139(6):887-890. PubMed ID: 31155531
[TBL] [Abstract][Full Text] [Related]
12. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
Bryans JS; Kettleborough CA; Solari R
Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
[No Abstract] [Full Text] [Related]
13. Discovery of PET radiopharmaceuticals at the academia-industry interface.
Bernard-Gauthier V; Collier TL; Liang SH; Vasdev N
Drug Discov Today Technol; 2017 Nov; 25():19-26. PubMed ID: 29233263
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
Kaski JC
Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
[No Abstract] [Full Text] [Related]
15. Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
Dhainaut JF; Blin O; Herry F; ; Benito S; Bilbault P; Cauterman M; Favrel-Feuillade F; Fazi-Leblanc S; Germain C; Goehrs C; Grosskopf C; Labarthe B; Lechat P; Malciu C; Marquet P; Miceli-Richard C; Peyret O; Rattenbach R; de Saint-Exupéry E
Therapie; 2020; 75(1):113-123. PubMed ID: 31948660
[TBL] [Abstract][Full Text] [Related]
16. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
Yamada H; Hirabayashi F; Brünger C
Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
[TBL] [Abstract][Full Text] [Related]
17. Biotechnology and new companies arising from academia.
Vallance P
Lancet; 2001 Nov; 358(9295):1804-6. PubMed ID: 11734259
[TBL] [Abstract][Full Text] [Related]
18. Accessing external innovation in drug discovery and development.
Tufféry P
Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
[TBL] [Abstract][Full Text] [Related]
19. Medical innovation then and now: perspectives of innovators responsible for transformative drugs.
Xu S; Kesselheim AS
J Law Med Ethics; 2014; 42(4):564-75. PubMed ID: 25565621
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
